Search Results
Slidesets
What is the Clinical support for reduce drug regimens? | Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Opening lecture: State of the Art lecture - Maria Buti, MD, PhD
Presented at:
Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 2015
Slidesets
#7_KimAnderson_Hospitalisation Patterns Among Infants With HIV in the Era of Universal Antiretroviral Therapy in South Africa_Slides
Presented at:
International Workshop on HIV & Pediatrics 2022
Slidesets
Addressing Stigma in Health Facilities: Why It Matters and How It Can be Done - Laura Nyblade, PhD
Presented at:
INTEREST 2022
Slidesets
Slide: Progress Towards Hepatitis C (HCV) Elimination in Punjab, India: An Update - Karan Singla
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2021
Slidesets
Understanding Viral Suppression- Daniel Kuritzkes, MD
Presented at:
Asia-Pacific HIV Clinical Forum 2017
Slidesets
Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhD
Presented at:
RespiDART 2018
Slidesets
Fatal Triple – Linking Obesity, Type-2 Diabetes, and NASH - Cyrielle Caussy, MD, PhD slides
Presented at:
Innovations in NAFLD Care Workshop 2022
Slidesets
SLC22a2 genetic variants and dolutegravir trough concentrations correlate with specific psychiatric symptoms in hiv-positive patients on dolutegravir- Alberto Borghetti
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022